Article
Efficacy and Safety of Guselkumab and Adalimumab for Pustulotic Arthro-Osteitis and their Impact on Peripheral Blood Immunophenotypes
2022-06-24
Abstract excerpt
<h4>Objectives: </h4> We compared the treatment effectiveness between guselkumab (GUS) and adalimumab (ADA) in patients with pustulotic arthro-osteitis (PAO). In addition, we performed peripheral blood immunophenotyping to elucidate the immunological background and analyzed the impact of therapeutic drugs to verify the validity of immunological phenotypes as therapeutic targets. <h4>Methods: </h4> Patients were tr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ff8e83aa-7dc8-562c-849a-47c5cc8d77ee
- DOI
- 10.21203/rs.3.rs-1771512/v1
